Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Featured Articles

Imaging Correlates of Molecular Signatures in Oligodendrogliomas

Joseph F. Megyesi, Edward Kachur, Donald H. Lee, Magdalena C. Zlatescu, Rebecca A. Betensky, Peter A. Forsyth, Yoshifumi Okada, Hikaru Sasaki, Masahiro Mizoguchi, David N. Louis and J. Gregory Cairncross
Joseph F. Megyesi
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Kachur
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald H. Lee
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdalena C. Zlatescu
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca A. Betensky
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter A. Forsyth
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshifumi Okada
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hikaru Sasaki
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiro Mizoguchi
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David N. Louis
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Gregory Cairncross
1Departments of Clinical Neurological Sciences, Radiology, and Oncology, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada; 2 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 3 Departments of Clinical Neurosciences and Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada; and 4 Department of Pathology and Neurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-04-0209 Published July 2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Molecular subsets of oligodendroglioma behave in biologically distinct ways. Their locations in the brain, rates of growth, and responses to therapy differ with their genotypes. Retrospectively, we inquired whether allelic loss of chromosomal arms 1p and 19q, an early molecular event and favorable prognostic marker in oligodendrogliomas, were reflected in their appearance on magnetic resonance imaging. Loss of 1p and 19q was associated with an indistinct border on T1 images and mixed intensity signal on T1 and T2. Loss of 1p and 19q was also associated with paramagnetic susceptibility effect and with calcification, a common histopathological finding in oligodendrogliomas. These data encourage prospective evaluation of molecular alterations and magnetic resonance imaging characteristics of glial neoplasms.

  • Received February 3, 2004.
  • Revision received March 27, 2004.
  • Accepted April 7, 2004.
View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 10 (13)
July 2004
Volume 10, Issue 13
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Imaging Correlates of Molecular Signatures in Oligodendrogliomas
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Imaging Correlates of Molecular Signatures in Oligodendrogliomas
Joseph F. Megyesi, Edward Kachur, Donald H. Lee, Magdalena C. Zlatescu, Rebecca A. Betensky, Peter A. Forsyth, Yoshifumi Okada, Hikaru Sasaki, Masahiro Mizoguchi, David N. Louis and J. Gregory Cairncross
Clin Cancer Res July 1 2004 (10) (13) 4303-4306; DOI: 10.1158/1078-0432.CCR-04-0209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Imaging Correlates of Molecular Signatures in Oligodendrogliomas
Joseph F. Megyesi, Edward Kachur, Donald H. Lee, Magdalena C. Zlatescu, Rebecca A. Betensky, Peter A. Forsyth, Yoshifumi Okada, Hikaru Sasaki, Masahiro Mizoguchi, David N. Louis and J. Gregory Cairncross
Clin Cancer Res July 1 2004 (10) (13) 4303-4306; DOI: 10.1158/1078-0432.CCR-04-0209
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS AND DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Featured Articles

  • Differential Effects of Delivery of Omega-3 Fatty Acids to Human Cancer Cells by Low-Density Lipoproteins versus Albumin
  • Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis Is Inhibited by Bcl-2 but Restored by the Small Molecule Bcl-2 Inhibitor, HA 14-1, in Human Colon Cancer Cells
  • Functionalization of Tumor Necrosis Factor-α Using Phage Display Technique and PEGylation Improves Its Antitumor Therapeutic Window
Show more Featured Articles

Molecular Oncology, Markers, Clinical Correlates

  • Prognostic Impact of Hypoxia-Inducible Factors 1α and 2α in Colorectal Cancer Patients
  • Nuclear Factor-κB Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer
  • Transcription Factor AP-2γ Is a Developmentally Regulated Marker of Testicular Carcinoma In situ and Germ Cell Tumors
Show more Molecular Oncology, Markers, Clinical Correlates
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement